Top Markets
#1 MowCat MowCat +48.96%
#2 Audiera Audiera +28.09%
#3 Velvet Velvet +27.19%
#4 Bermuda Shorts Bermuda Shorts +24.66%
#5 Biconomy Biconomy +22.49%
#6 aPriori aPriori +22.35%
#7 Quack AI Quack AI +21.37%
#8 Derive Derive +19.47%
#9 SkyAI SkyAI +14.21%
#10 Geodnet Geodnet +12.98%
Coin of the day
MowCat MowCat
설정
언어
한국어
통화
USD
테마
Graybug Vision, Inc. Graybug Vision, Inc.

Graybug Vision, Inc.

GRAY
주식 순위 #35305
Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical... Graybug Vision, Inc. is a biopharmaceutical company currently in its clinical development phase, dedicated to creating treatments for conditions affecting the eye's retina and optic nerve. Its flagship therapeutic, GB-102, is an injectable microparticle formulation of sunitinib administered directly into the eye. This compound is progressing through Phase I/IIa and IIb clinical trials for wet age-related macular degeneration, while also undergoing Phase IIa trials for diabetic macular edema. Furthermore, GB-102 is being explored as a treatment for diabetic retinopathy. The company's pipeline also includes GB-401, an intraocular implant designed to deliver a beta-adrenergic receptor inhibitor, intended for the management of primary open-angle glaucoma. Initially established as Graybug LLC in 2011, the firm rebranded to Graybug Vision, Inc. in 2016 and is headquartered in Redwood City, California.
주가
$2.70
마지막 동기화: 2023-05-17
시가총액
$4.13M
변동 (1일)
0.00%
변동 (1년)
0.00%
국가
US
거래 Graybug Vision, Inc. (GRAY)

카테고리

Healthcare
Graybug Vision, Inc. (GRAY)의 P/S 비율
2026 기준 P/S 비율 TTM: 0
Graybug Vision, Inc.의 최신 재무 보고서와 주가에 따르면 현재 P/S 비율(TTM)은 0입니다. 2026년 말 기준 P/S 비율은 0였습니다.
Graybug Vision, Inc.의 P/S 비율 기록 (2026 ~ 2026)
매년 말 P/S 비율
연도 P/S 비율 변화
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 P/S 비율
회사 P/S 비율 P/S 비율 차이 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
4.74 -
BE